Stereotaxic Instruments Market Growth Accelerated by Increasing Demand for Advanced Neurological Procedures
Stereotaxic instruments are essential medical devices used to perform precise minimally invasive procedures on the brain and spinal cord while observing three-dimensional coordinates of the targeted area. These instruments enable doctors to diagnose and treat various neurological conditions effectively with reduced recovery time and risks of complications for patients. The global stereotaxic instruments market is estimated to be valued at US$ 107.72 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
North
America dominated the market in 2023 and is expected to remain dominant over
the forecast period. Well developed healthcare infrastructure, rising geriatric
population undergoing neurosurgeries, and presence of major manufacturers in
the US and Canada are driving the North America stereotaxic instruments market.
Key
players operating in the stereotaxic instruments market are Recon Robotics
Inc., Lockheed Martin Corporation, Northrop Grumman Corporation, QinetiQ,
Thales SA, Kongsberg Gruppen, BAE Systems PLC, FLIR Systems Inc., Elbit Systems
Limited, Boston Dynamics Inc., Leonardo SpA, SMP Robotics, AeroVironment Inc.,
DJI, and Knight Scope. Major players are focusing on developing innovative
robotic surgical systems with navigation capabilities for precision neurosurgeries.
Get
more insights on this topic: https://www.newsstatix.com/stereotaxic-instruments-market-share-and-opportunity-analysis/
Comments
Post a Comment